Trials / Completed
CompletedNCT04452448
Analysis of I-Trace High Order Aberrations Induced by Wavefront Optimized Ablation Profiles
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This work aims at the analysis of ocular aberrations induced by wave front optimized ablation profiles WFO using I-Trace aberrometer (Ray -Tracing)
Detailed description
The iTrace (Tracey Technologies, Houston, Tx) is uniquely designed to combine Placido corneal topography with a ray tracing aberrometer to measure quality of vision in a patient. This work aims at the analysis of ocular aberrations induced by wave front optimized ablation profiles WFO using I-Trace aberrometer (Ray -Tracing)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | LASIK | All cases were operated upon using Wavelight Allegretto EX-500 excimer laser (Alcon Laboratories, Inc., Fort Worth, TX) with wave front optimized ablation profile WFO. The Moria II microkeratome (Moria, Anthony, France) was used in all cases. |
Timeline
- Start date
- 2018-01-10
- Primary completion
- 2020-05-30
- Completion
- 2020-06-10
- First posted
- 2020-06-30
- Last updated
- 2020-06-30
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04452448. Inclusion in this directory is not an endorsement.